You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Veselina Stefanova1, Valerie M Crowley2,3, Andrea M Weckman1,2,3
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Soluble urokinase-type plasminogen activator receptor (suPAR) shows promise as an early predictor for severe malaria outcomes in children. This biomarker could improve risk assessment and management strategies for severe malaria.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: